Latest Biotech News

Johns Hopkins University researchers introduced MIGHT, a novel AI framework for cancer screening enhancing sensitivity at a high specificity target of 98%. By employing multidimensional informed...

Novo Nordisk and Replicate Bioscience entered a strategic collaboration leveraging Replicate’s self-replicating RNA (srRNA) platform to develop novel therapeutics for obesity, type 2 diabetes, and...

Scientists at Guangzhou Medical University accomplished the first successful transplantation of a genetically modified pig lung into a brain-dead human recipient, maintaining lung function for...

Innovative studies employ PET/CT radiomics combined with clinical features to predict treatment response in Hodgkin lymphoma patients. These methodologies, leveraging advanced imaging biomarkers...

Cutting-edge single-cell sequencing and spatial transcriptomics technologies are transforming kidney transplantation research by elucidating intricate cellular dynamics within grafts. Studies...

Cleveland Clinic is expanding its use of Dyania Health’s artificial intelligence platform to streamline the clinical trial enrollment process. The system rapidly analyzes electronic health records...

Significant regulatory developments include the FDA approval of Eisai-Biogen’s subcutaneous Leqembi formulation and the recent resignations of three CDC leaders amid policy disagreements with the...

A robust multicenter study led by the IVY Network demonstrates that a single shot of the respiratory syncytial virus (RSV) vaccine provides significant protection against severe RSV illness and...

Alnylam Pharmaceuticals reported that its RNAi therapeutic zilebesiran failed to significantly reduce blood pressure in a pivotal Phase 2 study, casting uncertainty on the drug’s benefit as it...

Novo Nordisk has entered a $550 million multi-year collaboration with Replicate Bioscience to develop novel therapeutics targeting obesity, type 2 diabetes, and cardiometabolic conditions using...

San Diego-based Pleno has initiated an early-access program for its Raptor platform, which leverages 'hypercoding' technology with circularizable probes to simultaneously target tens of thousands...

UCLA researchers have engineered AlloCAR70-NKT, a novel allogeneic cell therapy harnessing genetically modified invariant natural killer T cells, to combat metastatic renal cell carcinoma...

The FDA has approved a subcutaneous formulation of Eisai and Biogen’s Alzheimer's therapy Leqembi, facilitating easier administration that could enhance patient adherence compared to the...

A Chinese research team at Guangzhou Medical University achieved the first pig lung transplantation into a human body, maintaining graft viability for nine days. Using CRISPR gene-editing to...

Johns Hopkins University scientists have developed Multidimensional Informed Generalized Hypothesis Testing (MIGHT), an AI-based framework that optimizes cancer screening tests by balancing high...

Researchers at the Salk Institute have identified a novel microprotein, SLC35A4-MP, essential for maintaining mitochondrial structure and regulating metabolic stress in mouse adipose tissue. This...

The FDA granted approval to Sanofi's BTK inhibitor rilzabrutinib, acquired through its $3.7 billion Principia Biopharma buyout, for the treatment of immune thrombocytopenia. This marks a...

Cytokinetics reported positive late-stage clinical trial results for aficamten, a cardiac myosin inhibitor, showing improved exercise capacity in patients with obstructive hypertrophic...

The FDA has approved a new subcutaneous formulation of Eisai and Biogen's Alzheimer’s drug Leqembi, marking an incremental step in the effort to compete with existing treatments like Eli Lilly's...

The biopharmaceutical sector continues to attract significant investment activity in 2025. Notable financings in August include Patient Square Capital raising over $3 billion for its healthcare...